Henry Chang (Fatty Liver Foundation, USA)

Henry Chang (Fatty Liver Foundation, USA)

(Speaker)
Henry E. Chang is the Executive Director of the Fatty Liver Foundation, where he leads efforts to improve patient outcomes for those with MASLD/MASH through education, advocacy, research, and policy collaborations. With over 30 years of experience in global health and patient advocacy, Henry has held leadership roles in both non-profit organizations and the life sciences industry, including at the Global Business Coalition on HIV/AIDS, Tuberculosis, and Malaria, Doctors of the World USA, and DuPont-Merck Pharmaceuticals. He co-chairs the Liver Forum's Patient Engagement in Drug Development: Leading Through Example Working Group and is an active member of the AASLD, contributing to the Steatotic Liver Disease Stakeholder Group and Practice Guidelines Committee. Henry has published extensively on liver disease and health policy. He holds a B.Sc. and Ph.D. in biochemistry and molecular biology from UCLA and is committed to advancing patient advocacy and improving global health outcomes.